These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15750380)

  • 1. Square pegs and round holes? A review of economic evaluation in complementary and alternative medicine.
    Hulme C; Long AF
    J Altern Complement Med; 2005 Feb; 11(1):179-88. PubMed ID: 15750380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is complementary and alternative medicine (CAM) cost-effective? A systematic review.
    Herman PM; Craig BM; Caspi O
    BMC Complement Altern Med; 2005 Jun; 5():11. PubMed ID: 15932647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Evaluation of Complementary and Alternative Medicine in Oncology: Is There a Difference Compared to Conventional Medicine?
    Huebner J; Prott FJ; Muecke R; Stoll C; Buentzel J; Muenstedt K; Micke O;
    Med Princ Pract; 2017; 26(1):41-49. PubMed ID: 27607437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capturing the value of complementary and alternative medicine: including patient preferences in economic evaluation.
    Hollinghurst S; Shaw A; Thompson EA
    Complement Ther Med; 2008 Feb; 16(1):47-51. PubMed ID: 18346629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary and alternative medicine in back pain utilization report.
    Santaguida PL; Gross A; Busse J; Gagnier J; Walker K; Bhandari M; Raina P
    Evid Rep Technol Assess (Full Rep); 2009 Jan; (177):1-221. PubMed ID: 20629474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and alternative medicine costs - a systematic literature review.
    Maxion-Bergemann S; Wolf M; Bornhöft G; Matthiessen PF; Wolf U
    Forsch Komplementmed; 2006; 13 Suppl 2():42-5. PubMed ID: 16883079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of economic evaluation in CAM: an introductory framework.
    Ford E; Solomon D; Adams J; Graves N
    BMC Complement Altern Med; 2010 Nov; 10():66. PubMed ID: 21067622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical review of complementary and alternative medicine use among people with arthritis: a focus upon prevalence, cost, user profiles, motivation, decision-making, perceived benefits and communication.
    Yang L; Sibbritt D; Adams J
    Rheumatol Int; 2017 Mar; 37(3):337-351. PubMed ID: 27889825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic analysis of complementary medicine: a systematic review.
    White AR; Ernst E
    Complement Ther Med; 2000 Jun; 8(2):111-8. PubMed ID: 10859604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluations and randomized trials in spinal disorders: principles and methods.
    Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
    Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health economic evaluation in complementary medicine: development within the last decades concerning local origin and quality.
    Ostermann T; Krummenauer F; Heusser P; Boehm K
    Complement Ther Med; 2011 Dec; 19(6):289-302. PubMed ID: 22036521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of alternative medical providers for the outpatient treatment of insured patients with back pain.
    Lind BK; Lafferty WE; Tyree PT; Sherman KJ; Deyo RA; Cherkin DC
    Spine (Phila Pa 1976); 2005 Jun; 30(12):1454-9. PubMed ID: 15959379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.
    van Tilburg MA; Palsson OS; Levy RL; Feld AD; Turner MJ; Drossman DA; Whitehead WE
    BMC Complement Altern Med; 2008 Jul; 8():46. PubMed ID: 18652682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration and reimbursement of complementary and alternative medicine by managed care and insurance providers: 2000 update and cohort analysis.
    Pelletier KR; Astin JA
    Altern Ther Health Med; 2002; 8(1):38-9, 42, 44 passim. PubMed ID: 11795621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrative review of complementary and alternative medicine use for back pain: a focus on prevalence, reasons for use, influential factors, self-perceived effectiveness, and communication.
    Murthy V; Sibbritt DW; Adams J
    Spine J; 2015 Aug; 15(8):1870-83. PubMed ID: 25962340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.